Soluble Fas levels in cerebro spinal fluid and serum of patients with multiple sclerosis and other neurological diseases

E. Ciusani, S. Frigeno, M. Golati, E. Corsini, C. Milanese, A. Nespolo, A. Salmagg

Research output: Contribution to journalArticle

Abstract

The process of apoptosis, or programmed cell death, is involved in the regulation of the immune response and in the elimination ot potentially autoreactive T-cells. Regulation of apoptosis can take place via interaction of Fas and Fas hgand; elevated levels of the soluble form of Fas (sFas) have been reported in sera of patients with autoimmune disorders. We assessed the levels of CSF and serum sFas antigen in 45 MS patients, 49 patients with other neurological disease and in sera of 40 healthy controls. Soluble Fas antigen was detected using a commercially available ELISA kit. In serum, no differences were detected between MS patients and controls. However, a statistically significant increase of sFas levels in patients with inflammatory disease was detected in sera. CSF sFas levels were similar between MS patients and patients with non-inflammatory neurological diseases, while a trend to increased levels in CSF of patients with inflammatory diseases was observed. However, a statistically significant correlation between CSF sFas level and BBB damage (AlbCSF/AlbS) was detected in non-MS neurological disease, but not in MS patients. The normalized ratio (sFasCSF/sFasSerum)/(AlbCSF/AlbSerum) was calculated and used as marker of intrathecal synthesis of sFas (Fas Index); a statistically significant increse in Fas Index was detected in MS patients compared to patients with noninflammatory neurological disease (11.20±7.55 vs 6.77±5.48; p

Original languageEnglish
Pages (from-to)70
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Multiple Sclerosis
Cerebrospinal Fluid
Serum
Apoptosis
CD95 Antigens
Cell Death
Enzyme-Linked Immunosorbent Assay
T-Lymphocytes
Antigens

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Soluble Fas levels in cerebro spinal fluid and serum of patients with multiple sclerosis and other neurological diseases. / Ciusani, E.; Frigeno, S.; Golati, M.; Corsini, E.; Milanese, C.; Nespolo, A.; Salmagg, A.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 70.

Research output: Contribution to journalArticle

@article{b5d907104c1f491eb6401869b8d41966,
title = "Soluble Fas levels in cerebro spinal fluid and serum of patients with multiple sclerosis and other neurological diseases",
abstract = "The process of apoptosis, or programmed cell death, is involved in the regulation of the immune response and in the elimination ot potentially autoreactive T-cells. Regulation of apoptosis can take place via interaction of Fas and Fas hgand; elevated levels of the soluble form of Fas (sFas) have been reported in sera of patients with autoimmune disorders. We assessed the levels of CSF and serum sFas antigen in 45 MS patients, 49 patients with other neurological disease and in sera of 40 healthy controls. Soluble Fas antigen was detected using a commercially available ELISA kit. In serum, no differences were detected between MS patients and controls. However, a statistically significant increase of sFas levels in patients with inflammatory disease was detected in sera. CSF sFas levels were similar between MS patients and patients with non-inflammatory neurological diseases, while a trend to increased levels in CSF of patients with inflammatory diseases was observed. However, a statistically significant correlation between CSF sFas level and BBB damage (AlbCSF/AlbS) was detected in non-MS neurological disease, but not in MS patients. The normalized ratio (sFasCSF/sFasSerum)/(AlbCSF/AlbSerum) was calculated and used as marker of intrathecal synthesis of sFas (Fas Index); a statistically significant increse in Fas Index was detected in MS patients compared to patients with noninflammatory neurological disease (11.20±7.55 vs 6.77±5.48; p",
author = "E. Ciusani and S. Frigeno and M. Golati and E. Corsini and C. Milanese and A. Nespolo and A. Salmagg",
year = "1997",
language = "English",
volume = "18",
pages = "70",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Soluble Fas levels in cerebro spinal fluid and serum of patients with multiple sclerosis and other neurological diseases

AU - Ciusani, E.

AU - Frigeno, S.

AU - Golati, M.

AU - Corsini, E.

AU - Milanese, C.

AU - Nespolo, A.

AU - Salmagg, A.

PY - 1997

Y1 - 1997

N2 - The process of apoptosis, or programmed cell death, is involved in the regulation of the immune response and in the elimination ot potentially autoreactive T-cells. Regulation of apoptosis can take place via interaction of Fas and Fas hgand; elevated levels of the soluble form of Fas (sFas) have been reported in sera of patients with autoimmune disorders. We assessed the levels of CSF and serum sFas antigen in 45 MS patients, 49 patients with other neurological disease and in sera of 40 healthy controls. Soluble Fas antigen was detected using a commercially available ELISA kit. In serum, no differences were detected between MS patients and controls. However, a statistically significant increase of sFas levels in patients with inflammatory disease was detected in sera. CSF sFas levels were similar between MS patients and patients with non-inflammatory neurological diseases, while a trend to increased levels in CSF of patients with inflammatory diseases was observed. However, a statistically significant correlation between CSF sFas level and BBB damage (AlbCSF/AlbS) was detected in non-MS neurological disease, but not in MS patients. The normalized ratio (sFasCSF/sFasSerum)/(AlbCSF/AlbSerum) was calculated and used as marker of intrathecal synthesis of sFas (Fas Index); a statistically significant increse in Fas Index was detected in MS patients compared to patients with noninflammatory neurological disease (11.20±7.55 vs 6.77±5.48; p

AB - The process of apoptosis, or programmed cell death, is involved in the regulation of the immune response and in the elimination ot potentially autoreactive T-cells. Regulation of apoptosis can take place via interaction of Fas and Fas hgand; elevated levels of the soluble form of Fas (sFas) have been reported in sera of patients with autoimmune disorders. We assessed the levels of CSF and serum sFas antigen in 45 MS patients, 49 patients with other neurological disease and in sera of 40 healthy controls. Soluble Fas antigen was detected using a commercially available ELISA kit. In serum, no differences were detected between MS patients and controls. However, a statistically significant increase of sFas levels in patients with inflammatory disease was detected in sera. CSF sFas levels were similar between MS patients and patients with non-inflammatory neurological diseases, while a trend to increased levels in CSF of patients with inflammatory diseases was observed. However, a statistically significant correlation between CSF sFas level and BBB damage (AlbCSF/AlbS) was detected in non-MS neurological disease, but not in MS patients. The normalized ratio (sFasCSF/sFasSerum)/(AlbCSF/AlbSerum) was calculated and used as marker of intrathecal synthesis of sFas (Fas Index); a statistically significant increse in Fas Index was detected in MS patients compared to patients with noninflammatory neurological disease (11.20±7.55 vs 6.77±5.48; p

UR - http://www.scopus.com/inward/record.url?scp=33746323693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746323693&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 70

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -